Home › Research › Clinical safety
The historical and projected prevalence of dysphagia in Aotearoa New Zealand
Philip Gunby, Josh McSkimming, Maggie‐Lee Huckabee. New Zealand Medical Journal, 2025-02-27
Topic: Risk, prevention and care in population studies
The prevalence of dysphagia in Aotearoa New Zealand is estimated to have been approximately 1.78% in 2020, with the biggest aetiological contributors being stroke, Alzheimer's disease and other dementias, and gastroesophageal reflux disease. These three causes made up 81.5% of all estimated dysphagia cases in 2019. The prevalence rate of dysphagia in Aotearoa New Zealand is projected to rise to 2.54%, reflecting the ageing population. An increased prevalence of dysphagia will result in an increased healthcare burden, both from resources spent on treating dysphagia and complications stemming from undiagnosed and thus untreated dysphagia. Estimating the full extent of this increased burden is hampered by the absence of systematic, extensive and reliable records available relating to cases of dysphagia in Aotearoa New Zealand.
Key findings
- The prevalence of dysphagia in Aotearoa New Zealand is estimated to have been approximately 1.78% in 2020, with the biggest aetiological contributors being stroke, Alzheimer's disease and other dementias, and gastroesophageal reflux disease.
- These three causes made up 81.5% of all estimated dysphagia cases in 2019.
- The prevalence rate of dysphagia in Aotearoa New Zealand is projected to rise to 2.54%, reflecting the ageing population.
- An increased prevalence of dysphagia will result in an increased healthcare burden, both from resources spent on treating dysphagia and complications stemming from undiagnosed and thus untreated dysphagia.
- Estimating the full extent of this increased burden is hampered by the absence of systematic, extensive and reliable records available relating to cases of dysphagia in Aotearoa New Zealand.
Why it matters
This study estimates how common dysphagia is in Aotearoa New Zealand and projects it will rise with an ageing population, with Alzheimer's disease and other dementias among the biggest contributing causes. It is about measuring and planning for swallowing problems, not about treating, curing or preventing Alzheimer's disease.
Study details
- Effect size1.78%; 81.5%; 2.54%
- Evidence strengthLow
How this study scored 33/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (New Zealand Medical Journal) |
| Journal's citation record | 0 / 4 | New Zealand Medical Journal: journal h-index 14 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Maggie‐Lee Huckabee: h-index 31 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Canterbury: institution h-index 466 (OpenAlex) |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40014770) |
| Free to read | 2 / 2 | Free to read |
| Total | 33 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.26635/6965.6404
- PubMed: 40014770
- Original source →
- Free full text: New Zealand Medical Journal →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Gunby, P., McSkimming, J., & Huckabee, M. (2025). The historical and projected prevalence of dysphagia in Aotearoa New Zealand. New Zealand Medical Journal. https://doi.org/10.26635/6965.6404
Vancouver
Gunby P, McSkimming J, Huckabee M. The historical and projected prevalence of dysphagia in Aotearoa New Zealand. New Zealand Medical Journal. 2025. doi:10.26635/6965.6404. PMID: 40014770.
BibTeX
@article{gunby2025-40014770,
author = {Gunby, Philip and McSkimming, Josh and Huckabee, Maggie‐Lee},
title = {{The historical and projected prevalence of dysphagia in Aotearoa New Zealand}},
journal = {New Zealand Medical Journal},
year = {2025},
doi = {10.26635/6965.6404},
pmid = {40014770},
url = {https://doi.org/10.26635/6965.6404}
}
Related studies in Clinical safety
Also in Clinical safety
96 studies in the library are filed under Clinical safety with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Clinical safety hub.